The Fas/FasL (CD95/CD178) system is required for immune regulation; however, it is unclear in which cells, when, and where Fas/FasL molecules act in the immune system. We found that CD8 as (CD95) and its ligand FasL (CD178) compose a unique system that is strongly related to programmed cell death (1) . FasL has been considered one of the effector molecules involved in the killing of target cells by cytotoxic T lymphocytes (CTLs) (2) . When Fas binds to FasL, it induces downstream signal transduction pathways that subsequently activate cell death induction pathways (3, 4) . Thus, the Fas/FasL system appears to act as an effector for CTL-mediated killing of virus-infected or cancer cells, similar to the perforin-granzyme system (5, 6) . However, because Fas-mutant (lpr) and FasL-deficient (gld) mice show lymphoproliferative changes, it has been suggested that the Fas/FasL system is important for suppression/regulation of activated effector T cells (7, 8) .
Molecular mechanisms after Fas activation have been thoroughly investigated, and the signal transduction pathway has been largely elucidated (9, 10) . However, research on the cellular events that use the Fas/FasL system has progressed comparatively slowly. There are only a few relevant reports in this respect, mostly of human CD4
+

Foxp3
+ Tregs that use the Fas/FasL system for their regulatory activity. [In this article, we use the term "Treg(s)" for any kind of T cells that show immune regulatory activity.] To complicate matters further, some contradictory reports claim that such Fas/ FasL-engaging Tregs do not exist (8, 11, 12) . No reliable reports suggesting that CD8
+ T cells use the Fas/FasL system for their regulatory action are available. Therefore, it is not clear precisely which subset of T cells express FasL or where Fas/FasL-dependent CD8 + Tregs, if such cells exist, are located and at which point they function. Thus, the ultimate pathophysiological role of the Fas/FasL system is still unknown.
Regulation of the immune reaction is of pivotal importance for maintaining health in multicellular organisms. In highly developed animals, Tregs, a subset of T lymphocytes especially known as CD4
+ cells, are the main regulators of the immune response (13) (14) (15) (16) . However, it is not quite clear whether CD8 + regulatory T cells exist; there are only few and contradictory reports on their existence, in contrast to the reports on CD4 + Tregs. A population of predominantly CD8
+ suppressor T cells has been described and debated in the 1980s (17, 18 
CD49d
low regulatory T cells induced apoptosis in target T cells depending on death receptor Fas (CD95)-FasL (CD178) interaction. This in vitro phenomenon reflected the regulatory activity of these cells in vivo, which was also reproducible in the in vivo experimental system of adoptive T-cell transfer. By using natural mutant mice of Fas or FasL and the gene-targeted mice of IL-10, we confirmed that the regulatory activity of CD8 + CD122 + CD49d low cells was mediated by Fas-FasL but not by IL-10. In addition, the necessity of MHC class I molecules on the target T cells was also confirmed by analysis using CD8 + T cells that lack β2-microglobulin and consequently class I MHC. an in vitro system, based on cell culture, and an in vivo system, based on adoptive transfer of T cells. Interestingly, CD8 + Tregs express CD122 (IL-2/IL-15 receptor β chain) in contrast to CD4 + Tregs, which express CD25 (IL-2 receptor α chain), indicating the fundamental importance of IL-2 at the development/maturation of both CD4 + and CD8 + Tregs. Suzuki and coworkers generated CD122-deficient mice using gene targeting (21) and used them to identify 122 + Tregs (22) . In this study, which is a follow-up study to our previous report, we performed in vitro and in vivo experiments to gain further understanding of these cells. We found that CD49d might be a good marker for classifying CD8 + T cells into naïve, resting T cells (CD62L + CD122 − ), effector memory T cells (CD62L − ), and T cells of central memory phenotype (CD122 + CD49d low ), by using multicolor staining of CD62L, CD122, and CD49d. To our knowledge, this is the first report on the role of the Fas/ FasL system in the action of CD8 + CD122 + Tregs (122 + Tregs) (22) (23) (24) (25) . Additionally, we show that CD8
+ Tregs are included in the CD49d low population, which corresponds to the central memory T-cell population, and that their mechanism of suppression depends on the cytotoxicity mediated by the Fas and FasL interaction. 
Results
CD8
CD122
+ population. We chose CD62L and CD49d; CD62L allows separation of effector memory T cells. CD122 is also frequently used as well as CD44 and CD62L for the analysis of memory and regulatory cells (26) . We examined the expression of these cell-surface markers in murine splenic T cells ( Fig. 1 A and B 
+ cells can be divided into two populations by their expression level of CD49d. Then, we performed an in vitro experiment in which candidate Tregs were cocultured with their target cells. As the mechanism of regulation by CD8 + Tregs is thought to involve elimination of the target cells (27) , candidate Tregs should reduce the number of target (regulated) cells during coculture. Representative results after 72 h of coculture are presented in Fig. 1 (Fig. 1C) . When CD122 − cells were cocultured with CD49d high cells, the decrease in the percentage of CD122 − cells was much less marked than when they were cocultured with CD49d low cells ( Fig. 1 C and D) . These results of relative change between two different cells cocultured were the reflection of the absolute number of live cells, which is presented in Fig. S1A .
These results indicate that CD8 
− cells. In contrast, the CD49d low cells clearly reversed the survival of mice to the level of those that had not received T cells (Fig. 1F, 
− cells from lpr mice to wild-type CD8
+
Tregs decreased as coculture continued ( Fig. 2 A and B) . However, the rate and extent of decrease were significantly higher when CD8 + CD122 − cells and CD8 + Tregs, both taken from wild-type mice, were cocultured ( Fig. 2 A and B) . These changes in the ratio of cell number were also observed in the data of absolute cell numbers (Fig.  S1B) . The proliferation rate of CD8 +
CD122
− cells from lpr mice was not different from that of CD8 + CD122 − cells from wild-type mice (Fig. 2C ). In addition, we examined the proliferation of cocultured cells by the dilution of prelabeled CFSE and further confirmed that any types of cells used in this study show a similar pattern of CFSE peaks (Fig. 2D ). This result confirmed that the difference observed between CD8 +
− cells from lpr mice and those from wild-type mice in the coculture experiment was not due to a difference in proliferation rate but due to resistance to apoptosis of the lpr micederived CD8 +
− cells. In the in vivo experiment, RAG-2-deficient mice that had received CD8 (Fig. 3A) . Furthermore, the existence of the FasL product on the cell surface was confirmed by flow cytometry (Fig. 3B ). This result indicated that FasL is a candidate mediator of killing of Fas-expressing target cells.
Next + Tregs from gld mice decreased over time; however, the rate and extent of decrease were significantly lower than when both types of cells were taken from wild-type mice ( Fig. 3 C  and D) . The difference was also observed in the absolute cell number (Fig. S1C) . The proliferation rate of CD8 + Tregs taken from gld mice was not different from that of wild-type CD8 + Tregs (Fig. 3E) 
− cells and could not prolong the survival of mice that received these cells.
CD8
+ Tregs Induce Apoptosis in Target-Activated CD8
To confirm the cytotoxic mechanisms underlying the regulatory action of CD8 + Tregs, we examined cell death during coculture by staining the cells with annexin V and 7-amino actinomycin D (7-AAD) (Fig. 4 A and B Judging from the experimental results both in vitro and in vivo, it is strongly suspicious that the regulatory mechanism performed by the CD49d low cells is elimination of cells by using the Fas/FasL system. To prove the involvement of the Fas/FasL system in our Tcell coculture assay, we introduced the assay system of PhiPhiLux and CaspaLux. It is well known that caspases are the key molecule of apoptosis, and caspase 8 is especially directly linked to the Fasderived signal. When caspase 8 is active, Caspalux-8, a substrate for caspase 8, is digested and becomes a fluorescent substance that can be detected by flow cytometry. As a result, more caspase 8-active cells were observed in the cells cocultured with CD49d low cells (Fig. 4 C and D (Fig. 4 E and F) . This finding indicates the existence of a negative feedback mechanism that controls the activity of CD8 + Tregs. (Fig. 5 A and B) . The rate and extent of reduction were lower than when they were cocultured with wildtype CD8
+ CD122 − cells (Fig. 5 A and B) . The proliferation of CD8 + CD122 − cells from mice in which the bone marrow had been reconstituted with that of β2-microglobulin-deficient mice was not significantly different from that of CD8 taken from wild-type mice (Fig. 5C ). This result confirmed that the recovery of the decrease in CD8 + CD122 − cells from the bone marrow-reconstituted mice, compared with that in cells from wildtype mice, was not due to a difference in the proliferation rate between the CD8 + CD122 − cells taken from the two different types of mice. Taken together, these results strongly indicate that CD8 + Tregs recognize their target cells by interaction between a MHC class I molecule (plus an antigen) and the TCR. Tregs, and the numbers of surviving cells were determined using flow cytometry. CD8 + Tregs were indeed able to reduce the number of CD4 + cells. This activity was evident for wild-type as well as lpr mouse-derived CD4 + cells; however, the activity of lprderived cells was significantly lower than that of wild-type CD4 + cells, indicating that it is Fas-dependent (Fig. 5 D and E) . The proliferation rate of CD4 + cells from lpr mice and that of wild-type cells was not significantly different (Fig. 5F ), indicating that it is Fas-dependent. The proliferation rates of CD4 + cells from lpr mice and that of wild-type cells were not significantly different (Fig. 5F ), indicating that the difference in the reduction speed in coculture was not due to a difference in proliferation rate per se but was due to the elimination of activated CD4
+ cells by CD8 + Tregs.
Discussion
The precise cellular events involved in the process of immune regulation related to Fas/FasL systems are largely unknown. Because Fas/FasL-mutated animals are prone to develop autoimmune diseases rather than immunodeficiency and FasL is known to be expressed in CD8 + cytotoxic T cells, it has been predicted that these cells are involved in immune regulation. Additionally, activated CD8 + T cells have been reported to kill clonally established T-cell lines; however, there is no firm evidence that the Fas/FasL system on particular CD8
+ T cells in fact regulates the immune response (28) . This is the first report describing that CD8 + Treg cells directly control CD8 
CD122
+ cells with a third marker, such as PD-1 (29), whereas such trials have not succeeded well in persuading other investigators. However, our experimental results obtained in the former studies (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) and the present studies have definitely shown the regulatory activity in this T-cell subset. Our current interpretation is that the regulatory and the memory functions are compatible. These cells with regulatory activity may belong to CD8 + memory T cells, possibly recognize self-antigens by their TCR, and induce apoptosis of Fas-expressing activated T cells. Based on our new understanding, it should be possible that cells with memory phenotype (CD8 (20) found that CD8 + CD122 + cells in murine peripheral immune organs can be divided into at least two populations according to their expression level of CD49d. The current study indicated that the final suppression mechanism used by the CD8 +
+ Tregs appears to be killing of the activated T cells, which depends on the Fas/ FasL pathway, because Fas-deficient T cells derived from lpr/lpr mice were resistant to killing (Fig. 2 A and B) and FasL-deficient Tregs derived from gld/gld mice could not perform this regulatory activity (Fig. 3 C and D) .
The molecular mechanism underlying immune suppression by CD8 + Tregs and the chemical pathway involved in the regulatory effect of these cells are still largely unknown. We previously reported that CD8 +
+ Tregs produce IL-10 and that the cytokine could be the effector molecule of these CD8 + Tregs. Although both the mechanism of recognition of target cells and the effector molecule of regulation by CD8
+ Tregs remain to be elucidated, this study yielded some important clues: Activation of Fas via interaction with FasL is largely associated with the killing of T cells that are no longer needed and rather harmful for survival. Another important molecular interaction is that of MHC class I and TCR. β2-microglobulin-deficient cells are neither regulated in the previous study (33) nor in the present study, suggesting the importance of specific recognition between "the regulatory cells" and "the regulated cells." Another important molecule involved in the action of CD8 + Tregs might be Qa-1, a nonclassical MHC class I molecule (MHC-Ib), as H. Cantor and his colleague found and reported a CD8 + T-cell subset that showed a regulatory activity under a Qa-1-restricted manner (30) . In their recent publications, however, the Qa-1-restricted CD8 + Tregs they proposed were apparently shown to be CD122 + CD44 + (34, 35) . The Qa-1-restricted CD8 + Treg is overlapped with or involved in the CD8 +
+ Treg reported by H. Suzuki and his colleagues (22) . Two CD8 + Tregs that were formerly thought to be distinct cell populations turned out to be the same one, further confirming the existence of CD8 + regulatory T cells, regardless of whether they are the naturally arising type or the induced type. Although the relation between CD4
+
Tregs and CD8
+ Tregs has not been clarified in detail, both Tregs are indispensable to maintain T-cell homeostasis, and their cooperative work has been suggested in the prevention and cure of an autoimmune disease (31) .
+ and CD4 + Tregs may pave the way to improve immune regulation by Tregs in clinical practice.
Materials and Methods
Mice. Animal care was performed according to the guidelines of Nagoya University (Nagoya, Japan). Experimental protocols were approved by the Ethics Committee of the Nagoya University Graduate School of Medicine (Nos. 27015, 27017, and 27365). old RAG-2-deficient mice that had received a sublethal dose of irradiation (5.5 Gym). The survival of the T-cell-recipient mice was followed up after adoptive T-cell transfer, and the results were analyzed using Kaplan-Meier survival curves.
Activation of CD8 + T Cells. CD8 + T cells in any desired population were collected from murine spleen and lymph node cells by using a FACS SORP Aria II cell sorter (BD Biosciences) and cultured in an anti-mCD3 antibody-coated 96-well plate for 24 h (1.0 × 10 5 cells per well).
T-Cell Culture. Activated T cells as described above were either cocultured or cultured alone in RPMI-1640 media containing 10% (vol/vol) FBS and 20 ng/mL of interleukin-2 (PeproTech Inc.) in a round-bottom 96-well plate for 72 h (0.5 × 10 5 cells per well).
For other information, see SI Materials and Methods.
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SI Materials and Methods
Mice. Six-to 8-wk-old C57BL/6 mice and gld and lpr mice of a C57BL/6 genetic background were purchased from SLC Japan. Breeding pairs of the C57BL/6 CD45.1/CD45.1 congenic strain and RAG-2-deficient mice on a C57BL/6 genetic background (B6.129S6-Rag2tm1FwaN12) were purchased from Taconic. β2-microglobulin-deficient mice and IL-10-deficient mice on a C57BL/6 genetic background (B6.129P2-Il10tm1Cgn/J) were originally obtained from the Jackson Laboratory. All mice were maintained in our animal facility.
Antibodies. FITC (fluorescein isothiocyanate)-conjugated antimouse CD122, PE (R-phycoerythrin)-or APC (allophycocyanin)-conjugated anti-mouse CD49d, PE-conjugated anti-mouse FasL, APC-conjugated anti-mouse CD62L, PE/Cy7-conjugated antimouse CD8a, and FITC-or APC-conjugated anti-mouse CD45.1 antibodies were purchased from BioLegend.
Cytotoxicity Assay. We used APC-conjugated anti-mouse CD45.1 antibody (BioLegend) and annexin V-FITC (BioLegend) with 7-AAD (eBioscience).
Activation of CD4
+ Naïve T Cells. CD4
+ T cells in any desired population were collected from murine spleen and lymph node cells by using an FACS Aria II cell sorter (BD Biosciences) and cultured and activated for 24 h in a 96-well plate (1.0 × 10 5 cells per well) using Dynabeads mouse T activator CD3/CD28 for activation of mouse T cells (In Vitrogen).
Real-Time PCR Primers. The following real-time PCR primers were used: CD163L1 A5, 5′-gtctggaaactgtcggagat-3′; CD163L1 A3, 5′-agtcttgtgacccctaaggt-3′; FasL A5, 5′-cgtgagttcaccaaccaaagc-3′; FasL A3, 5′-cccagtttcgttgatcacaag-3′; β-actin A5, 5′-agtgtgacgttgacatccgt-3′; and β-actin A3, 5′-gcagctcagtaacagtccgc-3′.
PhiPhiLux and CaspaLax. PhiPhiLux-G 2 D 2 kit and CaspaLux8-L 1 D2 kit systems that can detect the activity of caspase 3 and cspase 8, respectively, were purchased from OncoImmunin, Inc. 
SI Results
CD8
CD122
− cells (Fig. S2 A and B) . Furthermore, CD8
low cells from IL-10-deficient mice showed apparent activity in supporting the survival of RAG-2-deficient mice when they were transferred (R-phycoerythrin) into mice together with CD8 + CD122 − cells (Fig. S2C ). (Fig. S3A) and interpretation of the results (Fig. S3B) . The expression pattern of the unique gene CD163L1 that was highly expressed in CD8 + CD122 + CD49d low cells (36) , weakly expressed in CD8
high cells, and not expressed in other cells including CD4
+ cells (Fig. S3C ) was confirmed by real-time PCR results (Fig. S3D) . 
